Research Article
Sarcopenic Obesity and Cognitive Functioning: The Mediating Roles of Insulin Resistance and Inflammation?
Table 3
Coefficients predicting cognitive functioning for subjects aged 60–69.
| | Model 1 | Model 2 | Model 3 |
| Sarcopenic obese | −0.91 (1.30) | −0.83 (1.30) | −0.07 (1.31) | Solely sarcopenic | 1.14 (0.93) | 1.06 (0.93) | 1.33 (0.93) | Solely obese | 0.19 (0.62) | 0.44 (0.68) | 0.77 (0.64) | Black | −15.71 (0.93)*** | −15.71 (0.93)*** | −15.52 (0.93)*** | Hispanic | −12.03 (0.98)*** | −11.98 (0.98)*** | −12.19 (0.97)*** | Other | −7.52 (1.47)*** | −7.39 (1.47)*** | −8.61 (1.49)*** | Age | −1.08 (0.09)*** | −1.07 (0.09)*** | −1.06 (0.09)*** | Education | 2.80 (0.09)*** | 2.80 (0.09)*** | 2.74 (0.10)*** | Female | 9.25 (0.78)*** | 9.12 (0.79)*** | 9.48 (0.78)*** | Height | 0.15 (0.04)*** | 0.15 (0.04)*** | 0.15 (0.04)** | History of CVD | −2.24 (0.72)** | −2.21 (0.72)** | −1.96 (0.72)** | Low physical activity | −3.12 (0.62)*** | −3.06 (0.62)*** | −3.11 (0.62)*** | Hypoalbuminemia | −5.85 (1.29)*** | −5.58 (1.32)*** | −5.30 (1.29)*** | Hyperhomocysteinemia | −4.98 (1.15)*** | −4.99 (1.15)*** | −4.97 (1.15)*** | IRHOMA | | −0.37 (0.39) | | CRP | | | −1.01 (0.24)*** | squared | .472 | .472 | 0.475 |
|
|
.
|